Raffaela Casciello, Rosalinda Santonastaso, Martina Prisco, Ilaria Martino
{"title":"绿色创新与财务业绩。研发投资和环境、社会和治理信息披露的作用","authors":"Raffaela Casciello, Rosalinda Santonastaso, Martina Prisco, Ilaria Martino","doi":"10.1002/csr.2862","DOIUrl":null,"url":null,"abstract":"<p>This study investigates the effects of green innovation (GI) on financial performance under both accounting and market-based perspectives in European Union (EU) listed non-financial firms. In addition, this study explores whether the R&D investments and the Environmental, Social and Governance (ESG) disclosure play a mediating role over the association between GI and accounting-based and market-based financial performance, respectively. Based on a sample of 526 firms over the period 2012–2022, we find that GI is negatively associated with accounting-based financial performance and positively associated with market-based financial performance. We further find that GI impacts on accounting-based financial performance <i>via</i> the channel of R&D investments and on market-based financial performance <i>via</i> the channel of ESG disclosure. This study provides useful contributions to prior research by encouraging the adoption of an integrated perspective when evaluating potential effects of GI. This study can also assist managers in better preparing for the challenges of implementing GI by leveraging the ESG disclosure. It also advices to investors to carefully assess the more complex impact of GI on financial performance of the firm within their capital allocation decision-making process. In the same vein, it offers some insights to policy makers interested in facilitating the transition to a sustainable economy.</p>","PeriodicalId":8,"journal":{"name":"ACS Biomaterials Science & Engineering","volume":null,"pages":null},"PeriodicalIF":5.4000,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Green innovation and financial performance. The role of R&D investments and ESG disclosure\",\"authors\":\"Raffaela Casciello, Rosalinda Santonastaso, Martina Prisco, Ilaria Martino\",\"doi\":\"10.1002/csr.2862\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>This study investigates the effects of green innovation (GI) on financial performance under both accounting and market-based perspectives in European Union (EU) listed non-financial firms. In addition, this study explores whether the R&D investments and the Environmental, Social and Governance (ESG) disclosure play a mediating role over the association between GI and accounting-based and market-based financial performance, respectively. Based on a sample of 526 firms over the period 2012–2022, we find that GI is negatively associated with accounting-based financial performance and positively associated with market-based financial performance. We further find that GI impacts on accounting-based financial performance <i>via</i> the channel of R&D investments and on market-based financial performance <i>via</i> the channel of ESG disclosure. This study provides useful contributions to prior research by encouraging the adoption of an integrated perspective when evaluating potential effects of GI. This study can also assist managers in better preparing for the challenges of implementing GI by leveraging the ESG disclosure. It also advices to investors to carefully assess the more complex impact of GI on financial performance of the firm within their capital allocation decision-making process. In the same vein, it offers some insights to policy makers interested in facilitating the transition to a sustainable economy.</p>\",\"PeriodicalId\":8,\"journal\":{\"name\":\"ACS Biomaterials Science & Engineering\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2024-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Biomaterials Science & Engineering\",\"FirstCategoryId\":\"91\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/csr.2862\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Biomaterials Science & Engineering","FirstCategoryId":"91","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/csr.2862","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
本研究从会计和市场两个角度研究了绿色创新(GI)对欧盟(EU)上市非金融企业财务绩效的影响。此外,本研究还探讨了研发投资和环境、社会和治理(ESG)信息披露是否分别对绿色创新与基于会计和基于市场的财务绩效之间的关联起到中介作用。基于 2012-2022 年间 526 家公司的样本,我们发现,GI 与基于会计的财务绩效负相关,而与基于市场的财务绩效正相关。我们进一步发现,GI 通过研发投资渠道影响基于会计的财务绩效,通过 ESG 披露渠道影响基于市场的财务绩效。本研究鼓励在评估 GI 潜在影响时采用综合视角,从而为之前的研究做出了有益的贡献。这项研究还能帮助管理者更好地利用环境、社会和公司治理信息披露,为应对实施 GI 的挑战做好准备。它还建议投资者在其资本分配决策过程中,仔细评估 GI 对公司财务业绩的更复杂影响。同样,它也为有意促进向可持续经济过渡的政策制定者提供了一些见解。
Green innovation and financial performance. The role of R&D investments and ESG disclosure
This study investigates the effects of green innovation (GI) on financial performance under both accounting and market-based perspectives in European Union (EU) listed non-financial firms. In addition, this study explores whether the R&D investments and the Environmental, Social and Governance (ESG) disclosure play a mediating role over the association between GI and accounting-based and market-based financial performance, respectively. Based on a sample of 526 firms over the period 2012–2022, we find that GI is negatively associated with accounting-based financial performance and positively associated with market-based financial performance. We further find that GI impacts on accounting-based financial performance via the channel of R&D investments and on market-based financial performance via the channel of ESG disclosure. This study provides useful contributions to prior research by encouraging the adoption of an integrated perspective when evaluating potential effects of GI. This study can also assist managers in better preparing for the challenges of implementing GI by leveraging the ESG disclosure. It also advices to investors to carefully assess the more complex impact of GI on financial performance of the firm within their capital allocation decision-making process. In the same vein, it offers some insights to policy makers interested in facilitating the transition to a sustainable economy.
期刊介绍:
ACS Biomaterials Science & Engineering is the leading journal in the field of biomaterials, serving as an international forum for publishing cutting-edge research and innovative ideas on a broad range of topics:
Applications and Health – implantable tissues and devices, prosthesis, health risks, toxicology
Bio-interactions and Bio-compatibility – material-biology interactions, chemical/morphological/structural communication, mechanobiology, signaling and biological responses, immuno-engineering, calcification, coatings, corrosion and degradation of biomaterials and devices, biophysical regulation of cell functions
Characterization, Synthesis, and Modification – new biomaterials, bioinspired and biomimetic approaches to biomaterials, exploiting structural hierarchy and architectural control, combinatorial strategies for biomaterials discovery, genetic biomaterials design, synthetic biology, new composite systems, bionics, polymer synthesis
Controlled Release and Delivery Systems – biomaterial-based drug and gene delivery, bio-responsive delivery of regulatory molecules, pharmaceutical engineering
Healthcare Advances – clinical translation, regulatory issues, patient safety, emerging trends
Imaging and Diagnostics – imaging agents and probes, theranostics, biosensors, monitoring
Manufacturing and Technology – 3D printing, inks, organ-on-a-chip, bioreactor/perfusion systems, microdevices, BioMEMS, optics and electronics interfaces with biomaterials, systems integration
Modeling and Informatics Tools – scaling methods to guide biomaterial design, predictive algorithms for structure-function, biomechanics, integrating bioinformatics with biomaterials discovery, metabolomics in the context of biomaterials
Tissue Engineering and Regenerative Medicine – basic and applied studies, cell therapies, scaffolds, vascularization, bioartificial organs, transplantation and functionality, cellular agriculture